Armata Pharmaceuticals Inc. – Filings and Transcripts

NYSE American: ARMP
Share price (8/21/26): $5.10
Market cap (8/21/26): $190 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration

Registration of securities for employees

Ownership Filter

Gilmer Daniel B.

Gilmer Daniel B.

News Filter

Announces Financial Results for the Second Quarter 2026 and Provides a Corporate Update

Achieves Key Progress Across Clinical, Regulatory and Manufacturing Activities Supporting Planned Phase 3 Initiation of AP-SA02

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Receives Agreement From FDA on Initial Pediatric Study Plan for AP-SA02 for the Treatment of Complicated Staphylococcus Aureus Bacteremia

Change in Directors, Officers or Compensation

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission